Age groups*: |
|
|
Young children (0–5 years) |
16 (39 %) |
32 (70 %) |
School children (6–11 years) |
2 (5 %) |
3 (6 %) |
Adults (≥18 years) |
23 (56 %) |
11 (24 %) |
|
Route of exposure: |
|
|
Ingestion |
27 (66 %) |
43 (93 %) |
Inhalation |
8 (20 %) |
- |
Skin |
- |
1 (2 %) |
Eye |
2 (5 %) |
2 (4 %) |
Nasal mucosa |
1 (2 %) |
- |
Combination** |
3 (7 %) |
- |
|
Circumstances of exposure: |
|
|
Accidental exposure |
32 (78 %) |
45 (98 %) |
Attempted suicide |
1 (2 %) |
- |
Substance abuse |
2 (5 %) |
- |
Psychiatric disorder |
1 (2 %) |
- |
At work |
5 (12 %) |
- |
Other |
- |
1 (2 %) |
|
Symptoms at the time of CPCC call: |
|
|
None |
21 (51 %) |
32 (70 %) |
Mild*** |
19 (46 %) |
14 (30 %) |
Severe**** |
1 (2 %) |
- |